Nath Alok, Khan Ajmal, Hashim Zia, Patra Jeetendra Kumar
Department of Pulmonary Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Lung India. 2017 Mar-Apr;34(2):150-154. doi: 10.4103/0970-2113.201300.
The prevalence of hypersensitivity (AH) and allergic bronchopulmonary aspergillosis (ABPA) has been variably reported. Systematic data regarding sensitization and ABPA are lacking from this part of the country.
The aim of this study was to evaluate the prevalence of AH and ABPA in Uttar Pradesh.
This was prospective observational study. All patients attending outpatient Department of Pulmonary Medicine of our institute were included in the study.
Consecutive asthmatic patients underwent screening for ABPA using skin test (AST). Those showing a positive response to AST were further evaluated for ABPA.
During the study, 350 patients (192 males, 158 females, mean ± standard deviation age: 38.3 ± 12.8) were screened with AST. One hundred and twenty-three patients (35.1%) were tested positive for AST and 21.7% of patients were diagnosed as ABPA.
A high prevalence rate of ABPA was observed at our chest clinic. Although comparable with published data from other tertiary centers, it does not represent the true prevalence rates in asthmatics because of high chances of referral bias.
关于过敏性曲霉菌病(AH)和变应性支气管肺曲霉菌病(ABPA)的患病率,已有不同的报道。该国这一地区缺乏关于致敏和ABPA的系统数据。
本研究旨在评估北方邦AH和ABPA的患病率。
这是一项前瞻性观察性研究。本研究所呼吸内科门诊的所有患者均纳入研究。
连续的哮喘患者接受ABPA皮肤试验(AST)筛查。对AST呈阳性反应的患者进一步评估ABPA。
在研究期间,350例患者(192例男性,158例女性,平均±标准差年龄:38.3±12.8)接受了AST筛查。123例患者(35.1%)AST检测呈阳性,21.7%的患者被诊断为ABPA。
在我们的胸部诊所观察到ABPA的高患病率。尽管与其他三级中心公布的数据相当,但由于转诊偏倚的可能性很高,它并不代表哮喘患者的真实患病率。